Download PDF
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2021; 5(02): 116-118
DOI: 10.1055/s-0041-1727584
Case Report

Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma

Giancarlo Saal-Zapata
1   Interventional Neurosurgery Division, Clínica Angloamericana, San Isidro, Lima, Perú
,
Walter Durand
1   Interventional Neurosurgery Division, Clínica Angloamericana, San Isidro, Lima, Perú
,
Alfredo Ramos
1   Interventional Neurosurgery Division, Clínica Angloamericana, San Isidro, Lima, Perú
,
Raúl Cordero
2   Oncological Ophthalmology Division, Clínica Angloamericana, San Isidro, Lima, Perú
,
Rodolfo Rodríguez
1   Interventional Neurosurgery Division, Clínica Angloamericana, San Isidro, Lima, Perú
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Intra-arterial chemotherapy (IAC) is currently, the first-line treatment for retinoblastomas with successful cure rates. In difficult access or unsuccessful catheterization of the ophthalmic artery (OA), the middle meningeal artery is a second alternative followed by the Japanese technique using balloon. Nevertheless, when a well-developed posterior communicating artery is present, a retrograde approach to the OA through this vessel can be performed to deliver the chemotherapeutic drugs.

We present a case of an unsuccessful catheterization of the OA through the internal carotid artery due to a challenging configuration of the OA/carotid siphon angle and describe an alternative form of navigation and catheterization through the posterior circulation.

To our knowledge, this is the third report of a successful retrograde catheterization of the OA for IAC and constitutes an alternative route to deliver chemotherapy.

Keywords

retinoblastoma - intra-arterial chemotherapy - ophthalmic artery


Publication History

Article published online:
01 June 2021

© 2021. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Jabbour P, Chalouhi N, Tjoumakaris S. et al. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr 2012; 10 (03) 175-181
    CrossrefPubMedGoogle Scholar
  • 2 Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 2010; 117 (08) 1623-1629
    CrossrefPubMedGoogle Scholar
  • 3 Abramson DH, Daniels AB, Marr BP. et al. Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma. PLoS One 2016; 11 (01) e0146582
    CrossrefPubMedGoogle Scholar
  • 4 Manjandavida FP, Stathopoulos C, Zhang J, Honavar SG, Shields CL. Intra-arterial chemotherapy in retinoblastoma—a paradigm change. Indian J Ophthalmol 2019; 67 (06) 740-754
    CrossrefPubMedGoogle Scholar
  • 5 Wang L, Han M, Zhao J. et al. Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: results and short-term complications. Medicine (Baltimore) 2018; 97 (42) e12676
    CrossrefPubMedGoogle Scholar
  • 6 Wyse E, Handa JT, Friedman AD, Pearl MS. A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Pediatr Radiol 2016; 46 (09) 1223-1233
    CrossrefPubMedGoogle Scholar
  • 7 Dalvin LA, Kumari M, Essuman VA. et al. Primary intra-arterial chemotherapy for retinoblastoma in the intravitreal chemotherapy era: five years of experience. Ocul Oncol Pathol 2019; 5 (02) 139-146
    CrossrefPubMedGoogle Scholar
  • 8 Ravindran K, Dalvin LA, Pulido JS, Brinjikji W. Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis. J Neurointerv Surg 2019; 11 (12) 1266-1272
    CrossrefPubMedGoogle Scholar
  • 9 Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. Am J Neuroradiol 2012; 33 (08) 1608-1614
    CrossrefPubMedGoogle Scholar
  • 10 Quinn C, Tummala R, Anderson J, Dahlheimer T, Nascene D, Jagadeesan B. Effectiveness of alternative routes of intra-arterial chemotherapy administration for retinoblastoma: potential for response and complications. Interv Neuroradiol 2019; 25 (05) 556-561
    CrossrefPubMedGoogle Scholar
  • 11 Area C, Yen CJ, Chevez-Barrios P. et al. Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma. J Neurointerv Surg 2019; 11 (12) 1273-1276
    CrossrefPubMedGoogle Scholar
  • 12 Pham C-T, Blanc R, Lumbroso-Le L Rouic, Pistocchi S, Bartolini B, Piotin M. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma. Neuroradiology 2012; 54 (08) 845-848
    CrossrefPubMedGoogle Scholar
  • 13 Saglam M, Sarici A, Anagnostakou V. et al. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery. Neuroradiology 2014; 56 (09) 751-754
    CrossrefPubMedGoogle Scholar
  • 14 Arat YO, Arat A, Aydin K. Angiographic morphometry of internal carotid artery circulation in Turkish children. Turk Neuro-surg 2015; 25 (04) 608-616
    PubMedGoogle Scholar
  • 15 Dimaras H, Corson TW, Cobrinik D. et al. Retinoblastoma. Nat Rev Dis Primers 2015; 1: 15021
    CrossrefPubMedGoogle Scholar
  • 16 Yousef YA, Soliman SE, Astudillo PP. et al. Intra-arterial chemotherapy for retinoblastoma: a systematic review. JAMA Ophthalmol 2016; 134 (05) 584-591
    CrossrefPubMedGoogle Scholar